Josep Tabernero

J. Tabernero 400X400.jpg

Josep Tabernero, M.D., Ph.D., is currently Head of the Medical Oncology Department at the Vall d’Hebron University Hospital, Director of the Vall d’Hebron Institute of Oncology (VHIO) and Professor of Medicine at University of Vic - Central University of Catalonia (UVic-UCC). He has been Principal Investigator of several Phase 1 pharmacodynamic studies and translational projects with tumor-directed targeted therapies and immune-based therapies. 

His research aims at potentiating molecular therapies targeting specific oncoproteins and accelerating more effective personalized cancer medicines for patients displaying genetic lesions or pathway disregulation. 

Dr. Tabernero holds M.D. and Ph.D. degrees from the Universitat Autònoma de Barcelona, Spain. He serves on the Editorial Boards of various top tier journals including Annals of Oncology, ESMO Open, Cancer Discovery, Clinical Cancer Research, Cancer Treatment Reviews, and Nature Reviews Clinical Oncology. He has (co) authored approximately 500 peer-reviewed papers with an H-Index of 95.

J. Tabernero 400X400.jpg